Feodor Lynen

From WikiMD's Food, Medicine & Wellness Encyclopedia

Feodor Lynen with family 1964.jpg

Feodor Lynen (6 April 1911 – 6 August 1979) was a German biochemist who made significant contributions to the field of metabolism, particularly in the understanding of the cholesterol and fatty acid metabolism. His groundbreaking work in elucidating the pathway for the synthesis of acetyl-CoA, a key molecule in metabolism, earned him the Nobel Prize in Physiology or Medicine in 1964, which he shared with Konrad Bloch. Lynen's research has had a profound impact on the biochemical understanding of lipid metabolism and has paved the way for further research in the field.

Biography[edit | edit source]

Feodor Lynen was born in Munich, Germany, and spent the majority of his academic and professional life in his hometown. He studied chemistry at the University of Munich, where he later became a professor and directed the Institute for Cellular Chemistry. Throughout his career, Lynen was dedicated to understanding the complex processes of cellular metabolism, focusing particularly on how the body processes and utilizes fats.

Nobel Prize[edit | edit source]

The Nobel Prize awarded to Lynen and Bloch was in recognition of their discoveries concerning the mechanism and regulation of the cholesterol and fatty acid metabolism. Lynen's part of the work detailed how acetyl coenzyme A (acetyl-CoA) is involved in the biosynthesis of cholesterol and fatty acids, and how this process is regulated within the cell. This was a pivotal moment in biochemistry, as it shed light on the fundamental processes that are essential for life, and has implications for understanding diseases related to lipid metabolism, such as cardiovascular disease and obesity.

Research Contributions[edit | edit source]

Feodor Lynen's research contributions extend beyond his Nobel Prize-winning work. He was instrumental in identifying the roles of several coenzymes and enzymes in the metabolic pathway. His work on the citric acid cycle, and the role of acetyl-CoA in it, has been crucial in biochemistry. Lynen also explored the regulatory mechanisms that control metabolic pathways, including the feedback inhibition mechanism that regulates cholesterol synthesis.

Legacy[edit | edit source]

Lynen's legacy in the field of biochemistry is marked by his contributions to our understanding of metabolism. His work has influenced countless researchers and has laid the groundwork for the development of drugs that target metabolic pathways, such as statins for lowering cholesterol. The Feodor Lynen Research Fellowship, established by the Alexander von Humboldt Foundation, is named in his honor, supporting researchers at various stages of their careers.

Selected Publications[edit | edit source]

Feodor Lynen authored and co-authored numerous scientific papers throughout his career. Some of his most notable publications include studies on the synthesis and regulation of cholesterol and fatty acids, the role of coenzymes in metabolism, and the biochemical pathways of lipid metabolism.

Awards and Honors[edit | edit source]

In addition to the Nobel Prize, Lynen received several other prestigious awards and honors throughout his career, reflecting his significant contributions to the field of biochemistry. These include the Order of Merit of the Federal Republic of Germany, the Lasker Award, and honorary doctorates from several universities.

See Also[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD